Clinical research
Associated noncardiac congenital anomalies among cases with congenital heart defects

https://doi.org/10.1016/j.ejmg.2014.12.002Get rights and content

Abstract

Cases with congenital heart defects (CHD) often have other associated anomalies. The purpose of this investigation was to assess the prevalence and the types of associated anomalies in CHD in a defined population. The anomalies associated with CHD were collected in all live births, stillbirths and terminations of pregnancy during 26 years in 346,831 consecutive pregnancies of known outcome in the area covered by our population based registry of congenital anomalies. Of the 4005 cases with CHD born during this period (total prevalence of 115.5 per 10,000), 1055 (26.3%) had associated major anomalies. There were 354 (8.8%) cases with chromosomal abnormalities including 218 trisomies 21, and 99 (2.5%) nonchromosomal recognized dysmorphic conditions. There were no predominant recognized dysmorphic conditions, but VACTERL association. However, other recognized dysmorphic conditions were registered including Noonan syndrome, fetal alcohol syndrome, and skeletal dysplasias. Six hundred and two (15.0%) of the cases had non syndromic, non chromosomal multiple congenital anomalies (MCA). Anomalies in the urinary tract, the musculoskeletal, the digestive, and the central nervous systems were the most common other anomalies. Prenatal diagnosis was obtained in 18.7% of the pregnancies. In conclusion the overall prevalence of associated anomalies, which was one in four infants, emphasizes the need for a thorough investigation of cases with CHD. A routine screening for other anomalies may be considered in infants and in fetuses with CHD. One should be aware that the anomalies associated with CHD can be classified into a recognizable anomaly, syndrome or pattern in one out of nine cases with CHD.

Introduction

Studies of other defects associated with specific congenital anomalies may be helpful to understand embryonic development, identify the causes of congenital anomalies, determine recurrence risks, and guide expectations for the efficacy of prevention strategies [Stevenson et al., 2004]. Congenital heart defects are one of the most common congenital anomaly, representing approximately 45% of all prenatally diagnosed anomalies [Stoll et al., 2001] with a reported rate per 10,000 live births or total births varying from 43 to 124 [Lowry et al., 2013]. CHD occur in as many as 1 in 100 live births and in 1 in 500 fetal ultrasonographic examination [Meberg et al., 2007, Tegnander et al., 2006]. Many cases with CHD will have a coexisting defect involving noncardiac structures. Individual cases of CHD may differ widely in their cause. Specific genetic factors, such as chromosomal abnormalities and inherited mutations in developmental genes, or environmental influences on fetal development i.e. medications [Stoll et al., 1989] may form the underlying cause.

Although it has long been known that CHD are frequently associated with other congenital anomalies, their reported frequency and the type of associated anomalies observed vary considerably among different studies. Using data from our surveillance system of congenital anomalies over a 26-year period, we evaluated the nature and frequency of anomalies associated with CHD to identify recognizable conditions and specific patterns of associated anomalies, which could give hints about the pathogenesis of CHD.

Section snippets

Material and methods

Cases with anomalies for this study were derived from 346,674 consecutive pregnancies of known outcome, including live births and stillbirths, and 157 terminations of pregnancy for fetal abnormality regardless of gestational age, registered by our registry of congenital anomalies described previously [Stoll and Roth, 1985]. Minor anomalies were excluded according to EUROCAT [2009] guidelines for registration of congenital anomalies (http://www.eurocat-network.eu). Cases born in 11 maternity

Results

During the 26-year study period, 4005 infants with CHD were registered. Therefore, the total prevalence is 115.5 per 10,000 (Table 1). No trends in the frequency of CHD were noted during the time frame of the study. The early incidence of CHD over the period 1979 through 2004 was 115.5. Within the period the incidence varied from 97.9 in 1985 to 118.9 in 2001. The distribution and the prevalence of CHD in all malformed cases with CHD, in cases with isolated CHD and in cases with associated

Discussion

During the 26-year study period, the total prevalence of CHD was 115.5/10,000. The most frequent CHD were, (in parentheses the total prevalence per 10,000 and the percentage are given), VSD (44.2; 38), ASD (15.3; 13), PS and atresia (8.0; 7), CoA (5.7; 5), TGA (5.2; 4.5), AVSD (3.8; 3), AS and atresia (3.7; 3), and HLH (3.5; 3). Many studies to assess the prevalence of CHD and the proportion of CHD cases that are isolated compared to those that have extra cardiac associated anomalies have

Conflicts of interest

The authors declare there are no conflicts of interest.

References (59)

  • L.D. Botto et al.

    National Birth Defects Prevention Study, Seeking causes: classifying and evaluating congenital heart defects in etiologic studies

    Birth Defects Res. A Clin. Mol. Teratol.

    (2007)
  • J.P. Bound et al.

    Incidence of congenital heart disease in Blackpool, 1957–1971

    Br. Heart J.

    (1977)
  • C. Bower et al.

    Congenital heart disease: a 10 year cohort

    J. Paediatr. Child Health

    (1994)
  • E. Calzolari et al.

    Congenital heart defects: 15 years of experience of the Emilia–Romagna Registry (Italy)

    Eur. J. Epidemiol.

    (2003)
  • L.-E. Carlgren

    Incidence of congenital heart disease in children born in Gothenburg, 1941–1950

    Br. Heart J.

    (1959)
  • M. Csáky-Szunyogh et al.

    Risk and protective factors in the origin of conotruncal defects of heart–a population-based case–control study

    Am. J. Med. Genet. Part A

    (2013)
  • P. Dadvand et al.

    Descriptive epidemiology of congenital heart disease in Northern England

    Pediatr. Perinat. Epidemiol.

    (2009)
  • D.F. Dickinson et al.

    Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment

    Br. Heart J.

    (1981)
  • D. Dilber et al.

    Spectrum of congenital heart defects in Croatia

    Eur. J. Pediatr.

    (2010)
  • L. Eskedal et al.

    A population-based study of extra-cardiac anomalies in children with congenital cardiac malformations

    Cardiol. Young

    (2004)
  • EUROCAT Special Report

    Congenital Heart Defects in Europe 2000–2005

    (March 2009)
  • EUROCAT: http://www.eurocat-network.eu/....
  • R.H. Feldt et al.

    Incidence of congenital heart disease in children born to residents of Olmstead County, Minnesota, 1950–1969

    Mayo Clin. Proc.

    (1971)
  • C. Ferencz et al.

    Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study

    Am. J. Epidemiol.

    (1985)
  • C. Ferencz et al.

    Cardiac and noncardiac malformations observations in a population-based study

    Teratology

    (1987)
  • C. Ferencz et al.

    Epidemiology of cardiovascular malformations: the state of the art

    Cardiol. Young

    (1991)
  • A. Fung et al.

    Impact of prenatal risk factors on congenital heart disease in the current era

    J. Am. Heart Assoc.

    (2013)
  • D.C. Fyler

    Report of the New England regional infant cardiac program

    Pediatrics

    (1980)
  • P. Gallo et al.

    Congenital extracardial malformations accompanying congenital heart disease

    G. Ital. Cardiol.

    (1976)
  • Cited by (35)

    • A new era of genetic testing in congenital heart disease: A review

      2022, Trends in Cardiovascular Medicine
      Citation Excerpt :

      Syndromic CHD is generally distinguished by the presence of extracardiac anomalies (ECAs) alongside a cardiac defect. These may be subtle, warranting a thorough clinical evaluation of every child with CHD [8–11]. However, it is noteworthy that variants in genes most often associated with syndromic disease occasionally cause isolated CHD.

    • Congenital Heart Disease

      2021, Primary Care - Clinics in Office Practice
      Citation Excerpt :

      Reported prenatal risk factors include maternal ingestion of ethanol or prescription medications such as sodium valproate, retinoic acid, lithium, nonsteroidal antiinflammatory drugs, angiotensin-converting enzyme inhibitors, and paroxetine. During pregnancy, maternal infections such as rubella and cytomegalovirus and poorly controlled maternal diabetes are also well-described environmental risk factors associated with subsequent development of CHD.6,7 Environmental risk factors may also prompt referral for fetal echocardiogram and subsequent prenatal detection of CHD (Table 2).

    • Molecular systems in cardiovascular developmental disorders

      2019, Clinical Molecular Medicine: Principles and Practice
    • Pediatric general surgeon and critically ill cardiac patient

      2018, Critical Heart Disease in Infants and Children
    View all citing articles on Scopus
    View full text